Clinical Trial Update: A Clinical Trial Evaluating the Efficacy and Safety of Sanhuang Jingshiming Pills in the Treatment of nAMD [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the efficacy and safety of Sanhuang Jingshiming Pills for neovascular age-related macular degeneration. The study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• Sanhuang Jingshiming Pills

Snippet

Sponsor: Tasly Pharmaceutical Group Co., Ltd | Conditions: AMD | Phase 3 | Status: NOT_YET_RECRUITING